-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Evofem Biosciences, Inc. quarterly Depreciation history and growth rate from Q1 2023 to Q1 2024.
- Evofem Biosciences, Inc. Depreciation for the quarter ending March 31, 2024 was $12K, a 95.1% decline year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)